{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T04:06:30Z","timestamp":1767067590049,"version":"3.48.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Science Foundation of Hubei Province","award":["JCZRYB202500628"],"award-info":[{"award-number":["JCZRYB202500628"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["8217113494"],"award-info":[{"award-number":["8217113494"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-025-02529-w","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T12:05:40Z","timestamp":1764245140000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting the MAGED2-TRIM28-FLNC axis overcomes chemoresistance in TNBC via EMT suppression"],"prefix":"10.1186","volume":"23","author":[{"given":"Qifan","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sai","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yihao","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"issue":"1","key":"2529_CR1","first-page":"8299502","volume":"2024","author":"G LIU","year":"2024","unstructured":"Liu G, Zhang Y. Triple-Negative breast cancer treatment advancements: A review of evolving strategies. Eur J Cancer Care. 2024;2024(1):8299502.","journal-title":"Eur J Cancer Care"},{"key":"2529_CR2","doi-asserted-by":"publisher","first-page":"vi35","DOI":"10.1093\/annonc\/mds193","volume":"23","author":"MARTINM VON MINCKWITZ G","year":"2012","unstructured":"Von Minckwitz G Martinm. Neoadjuvant treatments for triple-negative breast cancer (TNBC). Ann Oncol. 2012;23:vi35\u20139.","journal-title":"Ann Oncol"},{"issue":"4","key":"2529_CR3","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1002\/(SICI)1097-0215(20000215)85:4<460::AID-IJC3>3.0.CO;2-N","volume":"85","author":"D JUNGBLUTH A A, BUSAM K J, KOLB","year":"2000","unstructured":"Jungbluth A A, Busam K J, Kolb D, et al. Expression of MAGE-antigens in normal tissues and cancer. Int J Cancer. 2000;85(4):460\u20135.","journal-title":"Int J Cancer"},{"issue":"6","key":"2529_CR4","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.molcel.2010.08.029","volume":"39","author":"JM DOYLE","year":"2010","unstructured":"Doyle JM, Gao J, Wang J, et al. MAGE-RING protein complexes comprise a family of E3 ubiquitin ligases. Mol Cell. 2010;39(6):963\u201374.","journal-title":"Mol Cell"},{"issue":"4","key":"2529_CR5","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.cell.2015.01.034","volume":"160","author":"T PINEDA C","year":"2015","unstructured":"Pineda C T, Ramanathan S, Fon Tacer K, et al. Degradation of AMPK by a cancer-specific ubiquitin ligase. Cell. 2015;160(4):715\u201328.","journal-title":"Cell"},{"issue":"4","key":"2529_CR6","doi-asserted-by":"publisher","first-page":"e312","DOI":"10.1038\/oncsis.2017.21","volume":"6","author":"X JIN","year":"2017","unstructured":"Jin X, PAN Y, Wang L, et al. MAGE-TRIM28 complex promotes the Warburg effect and hepatocellular carcinoma progression by targeting FBP1 for degradation. Oncogenesis. 2017;6(4):e312.","journal-title":"Oncogenesis"},{"issue":"7","key":"2529_CR7","doi-asserted-by":"publisher","first-page":"e101040","DOI":"10.1371\/journal.pone.0101040","volume":"9","author":"L CHEN","year":"2014","unstructured":"Chen L, Mu\u00f1oz-Antonia T, CresS Wd. Trim28 contributes to EMT via regulation of E-cadherin and N-cadherin in lung cancer cell lines. PLoS ONE. 2014;9(7):e101040.","journal-title":"PLoS ONE"},{"issue":"1","key":"2529_CR8","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12929-017-0374-4","volume":"24","author":"P CZERWI\u0143SKA","year":"2017","unstructured":"Czerwi\u0144ska P, Mazurek S. The complexity of TRIM28 contribution to cancer. J Biomed Sci. 2017;24(1):63.","journal-title":"J Biomed Sci"},{"key":"2529_CR9","doi-asserted-by":"crossref","unstructured":"Venuto S, Merla G. E3 ubiquitin ligase TRIM Proteins, cell cycle and mitosis. Cells. 2019;8(5).","DOI":"10.3390\/cells8050510"},{"key":"2529_CR10","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/0-387-29362-0_23","volume-title":"Bioinformatics and computational biology solutions using R and bioconductor","author":"GK Smyth","year":"2005","unstructured":"Smyth GK, limma. Linear models for microarray data. In: Gentleman R, et al. editors. Bioinformatics and computational biology solutions using R and bioconductor. New York, NY: Springer; 2005. pp. 397\u2013420.."},{"issue":"1","key":"2529_CR11","doi-asserted-by":"publisher","first-page":"3922","DOI":"10.1038\/s41467-024-47899-w","volume":"15","author":"H Peng","year":"2024","unstructured":"Peng H, Wang H, Kong W, et al. Optimizing differential expression analysis for proteomics data via high-performing rules and ensemble inference. Nat Commun. 2024;15(1):3922.","journal-title":"Nat Commun."},{"issue":"11","key":"2529_CR12","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1158\/2159-8290.CD-22-0200","volume":"12","author":"M ANURAG","year":"2022","unstructured":"Anurag M, Jaehnig E J, Krug K, et al. Proteogenomic markers of chemotherapy resistance and response in Triple-Negative breast cancer. Cancer Discov. 2022;12(11):2586\u2013605.","journal-title":"Cancer Discov"},{"key":"2529_CR13","doi-asserted-by":"crossref","unstructured":"Lee J. Current treatment landscape for early Triple-Negative breast cancer (TNBC). J Clin Med. 2023;12(4).","DOI":"10.3390\/jcm12041524"},{"issue":"6","key":"2529_CR14","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1038\/bjc.1995.231","volume":"71","author":"E KLUMPER","year":"1995","unstructured":"Klumper E, Pieters R, Den Boer M, L, et al. In vitro anthracycline cross-resistance pattern in childhood acute lymphoblastic leukaemia. Br J Cancer. 1995;71(6):1188\u201393.","journal-title":"Br J Cancer"},{"issue":"1","key":"2529_CR15","doi-asserted-by":"publisher","first-page":"100703","DOI":"10.1016\/j.mcpro.2023.100703","volume":"23","author":"X SHI","year":"2024","unstructured":"Shi X, Liu C, Zheng W, et al. Proteomic analysis revealed the potential role of MAGE-D2 in the therapeutic targeting of Triple-Negative breast cancer. Mol Cell Proteom. 2024;23(1):100703.","journal-title":"Mol Cell Proteom"},{"issue":"8","key":"2529_CR16","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.jmb.2017.03.005","volume":"429","author":"PR LEE A K, POTTS","year":"2017","unstructured":"Lee A K, Potts Pr. A comprehensive guide to the MAGE family of ubiquitin ligases. J Mol Biol. 2017;429(8):1114\u201342.","journal-title":"J Mol Biol"},{"key":"2529_CR17","doi-asserted-by":"crossref","unstructured":"Li Z, Chen S, Jhong JH, et al. UbiNet 2.0: a verified, classified, annotated and updated database of E3 ubiquitin ligase-substrate interactions. Database (Oxford). 2021.","DOI":"10.1093\/database\/baab010"},{"issue":"11","key":"2529_CR18","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/nri2413","volume":"8","author":"K OZATO","year":"2008","unstructured":"Ozato K, Shin D-M, Chang T-H, et al. TRIM family proteins and their emerging roles in innate immunity. Nat Rev Immunol. 2008;8(11):849\u201360.","journal-title":"Nat Rev Immunol"},{"key":"2529_CR19","doi-asserted-by":"crossref","unstructured":"Rousseaux MW, De Haro M, Lasagna-ReeveS CA, et al. TRIM28 regulates the nuclear accumulation and toxicity of both alpha-synuclein and Tau. Elife. 2016;5.","DOI":"10.7554\/eLife.19809"},{"issue":"2","key":"2529_CR20","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/cbin.10879","volume":"42","author":"GOLDMANN W H","year":"2018","unstructured":"Goldmann W H. Intermediate filaments and cellular mechanics. Cell Biol Int. 2018;42(2):132\u20138.","journal-title":"Cell Biol Int"},{"key":"2529_CR21","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1146\/annurev-biophys-050511-102252","volume":"41","author":"Z RAZINIA","year":"2012","unstructured":"Razinia Z, M\u00e4kel\u00e4 T, Yl\u00e4nne J, et al. Filamins in mechanosensing and signaling. Annu Rev Biophys. 2012;41:227\u201346.","journal-title":"Annu Rev Biophys"},{"issue":"5","key":"2529_CR22","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.breast.2010.03.026","volume":"19","author":"C OAKMAN","year":"2010","unstructured":"Oakman C, Viale G, Di Leo A. Management of triple negative breast cancer. Breast. 2010;19(5):312\u201321.","journal-title":"Breast"},{"issue":"5038","key":"2529_CR23","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1126\/science.1840703","volume":"254","author":"C VAN DER BRUGGEN P, TRAVERSARI","year":"1991","unstructured":"Van Der Bruggen P, TraversarI C, Chomez P, et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science. 1991;254(5038):1643\u20137.","journal-title":"Science"},{"issue":"11","key":"2529_CR24","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.3390\/ph17111447","volume":"17","author":"MH ALMUTAIRI","year":"2024","unstructured":"Almutairi Mh, Alsoraie W A, Alrubie T M, et al. Increased MAGE-C family gene expression levels as a biomarker of colon cancer through the demethylation mechanism. Pharmaceuticals. 2024;17(11):1447.","journal-title":"Pharmaceuticals"},{"issue":"6","key":"2529_CR25","doi-asserted-by":"publisher","first-page":"5101","DOI":"10.1016\/j.ygeno.2020.09.026","volume":"112","author":"R LI","year":"2020","unstructured":"Li R, Gong J. A comprehensive analysis of the MAGE family as prognostic and diagnostic markers for hepatocellular carcinoma. Genomics. 2020;112(6):5101\u201314.","journal-title":"Genomics"},{"issue":"2","key":"2529_CR26","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3390\/cancers16020246","volume":"16","author":"S VERMA","year":"2024","unstructured":"Verma S, Swain D, Kushwaha P P, et al. Melanoma antigen family A (MAGE A) as promising biomarkers and therapeutic targets in bladder cancer. Cancers. 2024;16(2):246.","journal-title":"Cancers"},{"key":"2529_CR27","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.bcp.2018.01.035","volume":"153","author":"C TRUSSART","year":"2018","unstructured":"Trussart C, Pirlot C, Di Valentin E, et al. Melanoma antigen-D2 controls cell cycle progression and modulates the DNA damage response. Biochem Pharmacol. 2018;153:217\u201329.","journal-title":"Biochem Pharmacol"},{"issue":"8022","key":"2529_CR28","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1038\/s41586-024-07690-9","volume":"631","author":"GS FRAN\u00e7A","year":"2024","unstructured":"Fran\u00e7a Gs, Baron M, King B R, et al. Cellular adaptation to cancer therapy along a resistance continuum. Nature. 2024;631(8022):876\u201383.","journal-title":"Nature"},{"issue":"6","key":"2529_CR29","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41580-020-0237-9","volume":"21","author":"J YANG","year":"2020","unstructured":"Yang J, Antin P, Berx G, et al. Guidelines and definitions for research on epithelial\u2013mesenchymal transition. Nat Rev Mol Cell Biol. 2020;21(6):341\u201352.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7","key":"2529_CR30","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1007\/s00204-021-03063-7","volume":"95","author":"A DE LAS RIVAS J, BROZOVIC","year":"2021","unstructured":"De Las Rivas J, BrozoviC A, Izraely S, et al. Cancer drug resistance induced by EMT: novel therapeutic strategies. Arch Toxicol. 2021;95(7):2279\u201397.","journal-title":"Arch Toxicol"},{"issue":"2","key":"2529_CR31","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1172\/JCI29544","volume":"117","author":"JL VENKOV C D, LINK A J, JENNINGS","year":"2007","unstructured":"Venkov C D, Link A J, Jennings Jl, et al. A proximal activator of transcription in epithelial-mesenchymal transition. J Clin Invest. 2007;117(2):482\u201391.","journal-title":"J Clin Invest"},{"issue":"1","key":"2529_CR32","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s41392-023-01450-3","volume":"8","author":"X MA","year":"2023","unstructured":"MA X, Jia S, Wang G, et al. TRIM28 promotes the escape of gastric cancer cells from immune surveillance by increasing PD-L1 abundance. Signal Transduct Target Ther. 2023;8(1):246.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2529_CR33","doi-asserted-by":"publisher","first-page":"5007","DOI":"10.1038\/s41467-018-07475-5","volume":"9","author":"B FONG K W, ZHAO J C, SONG","year":"2018","unstructured":"Fong K W, Zhao J C, Song B, et al. TRIM28 protects TRIM24 from SPOP-mediated degradation and promotes prostate cancer progression. Nat Commun. 2018;9(1):5007.","journal-title":"Nat Commun"},{"issue":"12","key":"2529_CR34","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1158\/2326-6066.CIR-21-0754","volume":"9","author":"J LIN","year":"2021","unstructured":"Lin J, Guo D, Liu H, et al. The SETDB1-TRIM28 complex suppresses antitumor immunity. Cancer Immunol Res. 2021;9(12):1413\u201324.","journal-title":"Cancer Immunol Res"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02529-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-025-02529-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02529-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T04:02:21Z","timestamp":1767067341000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12964-025-02529-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2529"],"URL":"https:\/\/doi.org\/10.1186\/s12964-025-02529-w","relation":{},"ISSN":["1478-811X"],"issn-type":[{"type":"electronic","value":"1478-811X"}],"subject":[],"published":{"date-parts":[[2025,11,27]]},"assertion":[{"value":"24 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal experiments of this study have been approved by the Laboratory Animal Management and Use Committee (IACUC) of Wuhan University (approval number: WQ20210094). Human tumor sections samples were collected post-surgery. Ethical approval was obtained from the Medical Ethics Committee of Zhongnan Hospital of Wuhan University (approval number: 2023002\u00a0K).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors were consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"551"}}